Mental Health in the Oncology Setting: General Considerations and Treatment Tips

Patients with comorbid mental health and substance use disorders are at greater risk for mortality and have higher cancer care costs. At JADPRO Live Virtual 2021, Lisa W. Goldstone, MS, PharmD, BCPS, BCPP, talked through general considerations in the oncology setting for persons with comorbid mental...

Descripción completa

Detalles Bibliográficos
Autor principal: Goldstone, Lisa W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126327/
https://www.ncbi.nlm.nih.gov/pubmed/35663165
http://dx.doi.org/10.6004/jadpro.2022.13.3.12
_version_ 1784712102313721856
author Goldstone, Lisa W.
author_facet Goldstone, Lisa W.
author_sort Goldstone, Lisa W.
collection PubMed
description Patients with comorbid mental health and substance use disorders are at greater risk for mortality and have higher cancer care costs. At JADPRO Live Virtual 2021, Lisa W. Goldstone, MS, PharmD, BCPS, BCPP, talked through general considerations in the oncology setting for persons with comorbid mental health or substance use disorders, strategies for recognizing when patients with new or preexisting mental health symptoms or disorders may benefit from treatment and/or referral, and first and second-line pharmacotherapy options.
format Online
Article
Text
id pubmed-9126327
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-91263272022-06-04 Mental Health in the Oncology Setting: General Considerations and Treatment Tips Goldstone, Lisa W. J Adv Pract Oncol Meeting Reports Patients with comorbid mental health and substance use disorders are at greater risk for mortality and have higher cancer care costs. At JADPRO Live Virtual 2021, Lisa W. Goldstone, MS, PharmD, BCPS, BCPP, talked through general considerations in the oncology setting for persons with comorbid mental health or substance use disorders, strategies for recognizing when patients with new or preexisting mental health symptoms or disorders may benefit from treatment and/or referral, and first and second-line pharmacotherapy options. Harborside Press LLC 2022-04 2022-05-23 /pmc/articles/PMC9126327/ /pubmed/35663165 http://dx.doi.org/10.6004/jadpro.2022.13.3.12 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Goldstone, Lisa W.
Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title_full Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title_fullStr Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title_full_unstemmed Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title_short Mental Health in the Oncology Setting: General Considerations and Treatment Tips
title_sort mental health in the oncology setting: general considerations and treatment tips
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126327/
https://www.ncbi.nlm.nih.gov/pubmed/35663165
http://dx.doi.org/10.6004/jadpro.2022.13.3.12
work_keys_str_mv AT goldstonelisaw mentalhealthintheoncologysettinggeneralconsiderationsandtreatmenttips

Ejemplares similares